Soo-Yeon Sohn , Brandon Gold , Janine Westra , William Westra
{"title":"人乳头瘤病毒基因型在头颈癌中的分布与人类免疫缺陷病毒状态的关系","authors":"Soo-Yeon Sohn , Brandon Gold , Janine Westra , William Westra","doi":"10.1016/j.oooo.2025.04.077","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Among the most transformative events in head and neck oncology over the past two decades has been the recognition that a significant fraction of head and neck squamous cell carcinoma (HNSCC) is caused by the human papillomavirus (HPV). The distribution of HPV genotypes in these HPV-HNSCCs diverges from patterns observed in anogenital cancers, but little is known about how complex interactions between viral exposures, modes of transmission, tissue susceptibilities, and other factors such as immunosuppression impact on genotype distribution. For example, patients who are human immunodeficiency virus (HIV) positive are at increased risk of developing HPV-HNSCC, but it is not known if these tumors are infected with different HPV genotypes compared to patients without HIV.</div></div><div><h3>Methods</h3><div>Data was collected for all patients with HNSCCs that had undergone HPV testing at an academic hospital as part of clinical care (2012-2019). Screening was performed using real-time PCR targeting L1 of low and high-risk HPV types, followed by genotyping of positive cases. Genotype status was correlated with HIV status. For HPV-HNSCCs, genotype distribution was compared for patients with and without HIV<em>.</em></div></div><div><h3>Results</h3><div>HPV testing had been performed on HNSCCs from 29 patients who were HIV positive. A total of 28 of 29 (97%) tumors were HPV positive. Of these, 18 (64%) harbored HPV16 and 10 (36%) harbored a non-16 variant. Compared to HPV-HNSCCs from patients who were HIV-negative, those from patients with HIV were more likely to be related to a non-16 variant.</div></div><div><h3>Conclusion</h3><div>For patients with HPV-HNSCCs, HPV genotypes are unevenly distributed across different patient populations as a function of HIV status. The finding challenges a prevailing assumption that HPV16 eclipses non-16 subtypes as the prevailing etiologic agent for all HPV-HNSCCs, and may inform developing therapeutic and surveillance strategies that depend on precise delineation of HPV genotype distribution across specific patient populations.</div></div>","PeriodicalId":49010,"journal":{"name":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","volume":"140 3","pages":"Pages e91-e92"},"PeriodicalIF":1.9000,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Human papillomavirus genotype distribution in head and neck cancer as a function of human Immunodeficiency virus status\",\"authors\":\"Soo-Yeon Sohn , Brandon Gold , Janine Westra , William Westra\",\"doi\":\"10.1016/j.oooo.2025.04.077\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Among the most transformative events in head and neck oncology over the past two decades has been the recognition that a significant fraction of head and neck squamous cell carcinoma (HNSCC) is caused by the human papillomavirus (HPV). The distribution of HPV genotypes in these HPV-HNSCCs diverges from patterns observed in anogenital cancers, but little is known about how complex interactions between viral exposures, modes of transmission, tissue susceptibilities, and other factors such as immunosuppression impact on genotype distribution. For example, patients who are human immunodeficiency virus (HIV) positive are at increased risk of developing HPV-HNSCC, but it is not known if these tumors are infected with different HPV genotypes compared to patients without HIV.</div></div><div><h3>Methods</h3><div>Data was collected for all patients with HNSCCs that had undergone HPV testing at an academic hospital as part of clinical care (2012-2019). Screening was performed using real-time PCR targeting L1 of low and high-risk HPV types, followed by genotyping of positive cases. Genotype status was correlated with HIV status. For HPV-HNSCCs, genotype distribution was compared for patients with and without HIV<em>.</em></div></div><div><h3>Results</h3><div>HPV testing had been performed on HNSCCs from 29 patients who were HIV positive. A total of 28 of 29 (97%) tumors were HPV positive. Of these, 18 (64%) harbored HPV16 and 10 (36%) harbored a non-16 variant. Compared to HPV-HNSCCs from patients who were HIV-negative, those from patients with HIV were more likely to be related to a non-16 variant.</div></div><div><h3>Conclusion</h3><div>For patients with HPV-HNSCCs, HPV genotypes are unevenly distributed across different patient populations as a function of HIV status. The finding challenges a prevailing assumption that HPV16 eclipses non-16 subtypes as the prevailing etiologic agent for all HPV-HNSCCs, and may inform developing therapeutic and surveillance strategies that depend on precise delineation of HPV genotype distribution across specific patient populations.</div></div>\",\"PeriodicalId\":49010,\"journal\":{\"name\":\"Oral Surgery Oral Medicine Oral Pathology Oral Radiology\",\"volume\":\"140 3\",\"pages\":\"Pages e91-e92\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-07-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oral Surgery Oral Medicine Oral Pathology Oral Radiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2212440325009460\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"DENTISTRY, ORAL SURGERY & MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Surgery Oral Medicine Oral Pathology Oral Radiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212440325009460","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
Human papillomavirus genotype distribution in head and neck cancer as a function of human Immunodeficiency virus status
Introduction
Among the most transformative events in head and neck oncology over the past two decades has been the recognition that a significant fraction of head and neck squamous cell carcinoma (HNSCC) is caused by the human papillomavirus (HPV). The distribution of HPV genotypes in these HPV-HNSCCs diverges from patterns observed in anogenital cancers, but little is known about how complex interactions between viral exposures, modes of transmission, tissue susceptibilities, and other factors such as immunosuppression impact on genotype distribution. For example, patients who are human immunodeficiency virus (HIV) positive are at increased risk of developing HPV-HNSCC, but it is not known if these tumors are infected with different HPV genotypes compared to patients without HIV.
Methods
Data was collected for all patients with HNSCCs that had undergone HPV testing at an academic hospital as part of clinical care (2012-2019). Screening was performed using real-time PCR targeting L1 of low and high-risk HPV types, followed by genotyping of positive cases. Genotype status was correlated with HIV status. For HPV-HNSCCs, genotype distribution was compared for patients with and without HIV.
Results
HPV testing had been performed on HNSCCs from 29 patients who were HIV positive. A total of 28 of 29 (97%) tumors were HPV positive. Of these, 18 (64%) harbored HPV16 and 10 (36%) harbored a non-16 variant. Compared to HPV-HNSCCs from patients who were HIV-negative, those from patients with HIV were more likely to be related to a non-16 variant.
Conclusion
For patients with HPV-HNSCCs, HPV genotypes are unevenly distributed across different patient populations as a function of HIV status. The finding challenges a prevailing assumption that HPV16 eclipses non-16 subtypes as the prevailing etiologic agent for all HPV-HNSCCs, and may inform developing therapeutic and surveillance strategies that depend on precise delineation of HPV genotype distribution across specific patient populations.
期刊介绍:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology is required reading for anyone in the fields of oral surgery, oral medicine, oral pathology, oral radiology or advanced general practice dentistry. It is the only major dental journal that provides a practical and complete overview of the medical and surgical techniques of dental practice in four areas. Topics covered include such current issues as dental implants, treatment of HIV-infected patients, and evaluation and treatment of TMJ disorders. The official publication for nine societies, the Journal is recommended for initial purchase in the Brandon Hill study, Selected List of Books and Journals for the Small Medical Library.